These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33706339)

  • 81. Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: study protocol for a randomized double blinded placebo-controlled comparison (Triple M Trial).
    van den Berg J; Hamel CC; Snijders MP; Coppus SF; Vandenbussche FP
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):443. PubMed ID: 31775677
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pharmacy Provision of Medication Abortion in Nepal: Pharmacy Owner and Worker Perspectives.
    Samari G; Puri M; Cohen R; Blum M; Rocca CH
    Int Perspect Sex Reprod Health; 2018 Sep; 44(3):81-89. PubMed ID: 30698524
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Abortion providers' experiences and views on self-managed medication abortion: an exploratory study.
    Kerestes CA; Stockdale CK; Zimmerman MB; Hardy-Fairbanks AJ
    Contraception; 2019 Aug; 100(2):160-164. PubMed ID: 31002777
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A telemedicine model for abortion in South Africa: a randomised, controlled, non-inferiority trial.
    Endler M; Petro G; Gemzell Danielsson K; Grossman D; Gomperts R; Weinryb M; Constant D
    Lancet; 2022 Aug; 400(10353):670-679. PubMed ID: 36030811
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Results of a large multicenter trial in the United States. Mifepristone Clinical Trials Group.
    Winikoff B; Ellertson C; Elul B; Sivin I
    Arch Fam Med; 1998; 7(4):360-6. PubMed ID: 9682690
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy.
    Dabash R; Chelli H; Hajri S; Shochet T; Raghavan S; Winikoff B
    Int J Gynaecol Obstet; 2015 Jul; 130(1):40-4. PubMed ID: 25896965
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion.
    Winikoff B; Sivin I; Coyaji KJ; Cabezas E; Xiao B; Gu S; Du MK; Krishna UR; Eschen A; Ellertson C
    Am J Obstet Gynecol; 1997 Feb; 176(2):431-7. PubMed ID: 9065194
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Methotrexate and misoprostol for early abortion: a multicenter trial. Acceptability.
    Creinin MD; Burke AE
    Contraception; 1996 Jul; 54(1):19-22. PubMed ID: 8804803
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A direct-to-patient telemedicine abortion service in Australia: Retrospective analysis of the first 18 months.
    Hyland P; Raymond EG; Chong E
    Aust N Z J Obstet Gynaecol; 2018 Jun; 58(3):335-340. PubMed ID: 29603139
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A harm-reduction model of abortion counseling about misoprostol use in Peru with telephone and in-person follow-up: A cohort study.
    Grossman D; Baum SE; Andjelic D; Tatum C; Torres G; Fuentes L; Friedman J
    PLoS One; 2018; 13(1):e0189195. PubMed ID: 29320513
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Towards safe abortion access: an exploratory study of medical abortion in Cambodia.
    Petitet PH; Ith L; Cockroft M; Delvaux T
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):47-55. PubMed ID: 25702068
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Client-pharmacy worker interactions regarding medical abortion in Zambia in 2009 and 2011.
    Hendrickson C; Fetters T; Mupeta S; Vwallika B; Djemo P; Raisanen K
    Int J Gynaecol Obstet; 2016 Feb; 132(2):214-8. PubMed ID: 26604158
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled Trial.
    Li CL; Song LP; Tang SY; Zhou LJGY; He H; Mo XT; Liao YM
    Reprod Sci; 2017 May; 24(5):731-737. PubMed ID: 27678099
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Early medical abortion using low-dose mifepristone followed by buccal misoprostol: a large Australian observational study.
    Goldstone P; Michelson J; Williamson E
    Med J Aust; 2012 Sep; 197(5):282-6. PubMed ID: 22938126
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam.
    Blum J; Raghavan S; Dabash R; Ngoc Nt; Chelli H; Hajri S; Conkling K; Winikoff B
    Int J Gynaecol Obstet; 2012 Aug; 118(2):166-71. PubMed ID: 22682768
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Ovulation resumption after medical abortion with mifepristone and misoprostol.
    Schreiber CA; Sober S; Ratcliffe S; Creinin MD
    Contraception; 2011 Sep; 84(3):230-3. PubMed ID: 21843685
    [TBL] [Abstract][Full Text] [Related]  

  • 99. How often and under which circumstances do Mexican pharmacy vendors recommend misoprostol to induce an abortion?
    Lara D; García SG; Wilson KS; Paz F
    Int Perspect Sex Reprod Health; 2011 Jun; 37(2):75-83. PubMed ID: 21757422
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Use of mifepristone and sublingual misoprostol for early medical abortion.
    Lin M; Li YT; Chen FM; Wu SF; Tsai CW; Chen TH; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):321-4. PubMed ID: 17175490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.